Session » Abstracts: RA – Diagnosis, Manifestations, & Outcomes II: Heart & Lung (1915–1918)
- 2:00PM-2:15PM
-
Abstract Number: 1915
Risk of Cardiovascular Outcomes with Low-Dose Glucocorticoids in Patients with Rheumatoid Arthritis
- 2:15PM-2:30PM
-
Abstract Number: 1916
Antibodies to Malondialdehyde-Acetaldehyde (MAA) Modified Proteins Predict Incident Rheumatoid Arthritis-Associated Interstitial Lung Disease
- 2:30PM-2:45PM
-
Abstract Number: 1917
Sputum TGF-β1 Is Elevated in Subclinical and Clinically Significant Rheumatoid Arthritis-Associated Interstitial Lung Disease and Correlates with Soluble IL-6R Levels
- 2:45PM-3:00PM
-
Abstract Number: 1918
Don’t Forget About the Arthritis in RA-ILD! Impact of Pulmonary and RA Disease Severity on Survival